Trade

Krsnaa Diagnostics share price

Balanced risk
  • 32%Low risk
  • 32%Moderate risk
  • 32%Balanced risk
  • 32%High risk
  • 32%Extreme risk
  • 709.50(0.99%)
    January 22, 2026 15:28:47 PM IST
    • NSE
    • BSE
  • Vol : 29.13 K (NSE + BSE)
    Last 20 day avg : 72.00 K

Krsnaa Diagnostics is trading 0.99% upper at Rs 709.50 as compared to its last closing price. Krsnaa Diagnostics has been trading in the price range of 720.10 & 687.85. Krsnaa Diagnostics has given -2.70% in this year & -3.17% in the last 5 days. Krsnaa Diagnostics has TTM P/E ratio 28.95 as compared to the sector P/E of 26.02.There are 3 analysts who have initiated coverage on Krsnaa Diagnostics. There are 2 analysts who have given it a strong buy rating & 1 analysts have given it a buy rating. 0.00 analysts have given the stock a sell rating.The company posted a net profit of 23.95 Crores in its last quarter.Listed peers of Krsnaa Diagnostics include Fortis Healthcare (-0.22%), Narayana Hrudayalaya (-2.58%), Global Health (2.20%).The Mutual Fund holding in Krsnaa Diagnostics was at 10.15% in 31 Dec 2025. The MF holding has decreased from the last quarter. The FII holding in Krsnaa Diagnostics was at 4.17% in 31 Dec 2025. The FII holding has increased from the last quarter.

  • Overview
  • Financials
  • Forecast
  • Technical Analysis
  • Peers
  • Shareholding
  • About the company
  • FAQ

Overview

  • 1 D
  • 5 D
  • 1 M
  • 3 M
  • 6 M
  • 1 Y
  • 5 Y
  • MAX
Explore on
Loading...
Key Metrics

Updated on Jan 22, 2026, 02:45 PM UTC

  • Beta
    Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
    0.19
    Low volatility
  • Debt To Equity
    The debt-to-equity ratio, indicating a company's financial leverage.
    0.23
    Lower than industry
  • Dividend Yield
    Annual dividends as a percentage of the stock price.
    0.39
    Lower than industry
  • PEG Ratio
    The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
    28.56
    Indicates overvaluation
  • P/E
    Price-to-earnings ratio based on trailing 12-month earnings
    -
  • P/B
    The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
    -
Price range
Day Range
Lowest
687.85
Highest
720.10
52 week range
Lowest
628.00
Highest
914.95
Krsnaa Diagnostics Peers
Return Comparison
Peers Comparison
Names
Technical ratingPrice%ChangeMarket CapP/EP/BDividend YieldDebt to Equity
Fortis Healthcare
Bearish
842.60-0.2263,649.9180.047.640.1125.92
Narayana Hrudayalaya
Bearish
1,769.00-2.5836,183.3147.6610.510.2459.03
Global Health
Bearish
1,071.302.2028,564.2861.739.450.0418.41
Max Healthcare Institute
Bearish
999.00-0.5697,428.6293.4311.210.1429.50
Apollo Hospitals Enterprise
Bearish
6,807.95-0.2897,885.7571.0912.560.2683.18
Mutual Fund Ownership
View all
Tata Small Cap Fund Regular Growth
3/5
  • Amount Invested (Cr.) 159.79
  • % of AUM 1.52
Kotak Healthcare Fund Regular Growth
NA
  • Amount Invested (Cr.) 6.41
  • % of AUM 1.47
Bandhan Small Cap Fund Regular Growth
4/5
  • Amount Invested (Cr.) 33.54
  • % of AUM 0.29
Bandhan BSE Healthcare Index Fund Regular Growth
NA
  • Amount Invested (Cr.) 0.02
  • % of AUM 0.09
Krsnaa Diagnostics Corporate Actions
View all
  • Board Meetings
  • AGM
  • Dividends
  • Bonus
  • Split
  • Rights
Meeting DatePurpose
2025-11-07Quarterly Results
2025-08-11Quarterly Results
2025-05-12Audited Results & Final Dividend
2025-02-12Quarterly Results
2024-10-25Quarterly Results
About the company Krsnaa Diagnostics
  • IndustryHealthcare Facilities
  • ISININE08LI01020
  • BSE Code543328
  • NSE CodeKRSNAA
Krsnaa Diagnostics Limited is engaged in the business of providing diagnostic services primarily in relation to pathology investigation, radiology investigation, and tele reporting. The Company’s services include pathology, X-Ray and computed tomography (CT) scans, magnetic resonance imaging (MRI), ultrasonography (USG), tele-radiology, tele-pathology, and other diagnostic services. Its laboratory services span a diverse range of investigations, ranging from CBC or blood glucose to highly specialized tests. Its tele-radiology services enable radiologists to offer treatment remotely. Tele-radiology involves transmitting radiological images, such as CT scans, digitized X-rays, MRIs, and ultrasounds between different locations. It offers Ayaksham package, which includes from basic to total plus health checkups. It provides diagnostic testing packages for diabetes, heart health, liver health, kidney health, thyroid, fatigue, cancer, senior citizen care, bone health, and others.
  • Management Info
  • Rajendra MuthaExecutive Chairman
  • Mitesh DaveGroup Chief Executive Officer
  • Pawan DagaChief Financial Officer
  • Ravinder SethiChief Operating Officer
  • Sujoy BoseCompliance Officer, Company Secretary
  • Dharmendra SharmaVice President - Operations
  • Abhijeet PatilVice President - Radiology
  • Pallavi BhatevaraExecutive Director
  • Manish KarekarChief Operating Officer - Pathology
Krsnaa Diagnostics Share Price FAQs

Krsnaa Diagnostics is trading at 709.50 as on Thu Jan 22 2026 09:58:47. This is 0.99% upper as compared to its previous closing price of 702.55.

The market capitalization of Krsnaa Diagnostics is 2300.06 Cr as on Thu Jan 22 2026 09:58:47.

The average broker rating on Krsnaa Diagnostics is Strong Buy. The breakup of analyst rating is given below -

  • 2 analysts have given a strong buy rating
  • 1 analysts have given a buy rating
  • 0.00 analysts have given a hold rating
  • 0.00 analysts have given a sell rating
  • 0.00 analysts have given a strong sell rating

The 52 wk high for Krsnaa Diagnostics is 914.95 whereas the 52 wk low is 628.00

Krsnaa Diagnostics can be analyzed on the following key metrics -

  • TTM P/E: 28.95
  • Sector P/E: 26.02
  • Dividend Yield: 0.39%
  • D/E ratio: 0.31

Krsnaa Diagnostics reported a net profit of 77.61 Cr in 2025.

The Mutual Fund Shareholding was 10.15% at the end of 31 Dec 2025.